Kestra Private Wealth Services’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.2K Sell
21,203
-7,606
-26% -$39.7K ﹤0.01% 1692
2025
Q4
$144K Sell
28,809
-2,238
-7% -$11.7K ﹤0.01% 1629
2025
Q3
$157K Sell
31,047
-1,077
-3% -$4.74K ﹤0.01% 1585
2025
Q2
$138K Sell
32,124
-5,554
-15% -$27.4K ﹤0.01% 1537
2025
Q1
$227K Sell
37,678
-6,100
-14% -$30.8K ﹤0.01% 1328
2024
Q4
$173K Buy
43,778
+3,160
+8% +$14.2K ﹤0.01% 1332
2024
Q3
$241K Buy
40,618
+5,575
+16% +$27.5K ﹤0.01% 1184
2024
Q2
$156K Sell
35,043
-1,520
-4% -$7.28K ﹤0.01% 1259
2024
Q1
$172K Buy
+36,563
New +$140K ﹤0.01% 1211
2020
Q4
Sell
-15,677
Closed -$276K 769
2020
Q3
$276K Buy
+15,677
New +$292K 0.02% 506

Other funds holding MPT

Kestra Private Wealth Services's MPT Position: Q1 2026 in Review

Kestra Private Wealth Services reduced its Medical Properties Trust (MPT) stake by 26% in Q1 2026, selling an estimated $39.7K and leaving 21,203 shares worth $98.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Kestra Private Wealth Services first reported a position in MPT in Q3 2020 and has held it in 10 quarters since. The position peaked at $276K in Q3 2020. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Kestra Private Wealth Services held 21,203 shares of Medical Properties Trust worth $98.2K as of Q1 2026.
  • Kestra Private Wealth Services sold 7,606 Medical Properties Trust shares in Q1 2026, an estimated $39.7K.
  • Medical Properties Trust made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #1692 holding.
  • Kestra Private Wealth Services first reported a position in Medical Properties Trust in Q3 2020 and has held it in 10 quarters since.
  • Kestra Private Wealth Services's Medical Properties Trust position peaked at $276K in Q3 2020.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.